Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Bristol-Myers Squibb renews support for Aids initiative

Bristol-Myers Squibb renews support for Aids initiative

12th August 2010

Bristol-Myers Squibb has underlined its commitment to combating HIV and Aids by offering renewed support for Aids drug assistance programmes (ADAPs) in the US.

The biopharmaceutical firm has agreed to step up its multi-year support for the ADAP Crisis Task Force's efforts to provide antiretroviral medicines to sufferers of the conditions.

This will involve provision of Bristol-Myers Squibb medication such as Reyataz and Sustiva and builds on an agreement originally signed in March 2010.

In addition, the company conducts a number of its own access to medicines initiatives for Aids patients, including the Access Virology scheme and the Atripla Co-Pay Assistance Program, conducted in association with Gilead Sciences.

Raymond Sacchetti, senior vice-president of virology at Bristol-Myers Squibb, said this commitment is necessary in dealing with a "challenging public health need".

Last month, the company published data from a survey which highlighted the role played by emotional issues in HIV and Aids treatment, with many sufferers feeling too ashamed or fearful to seek medical aid.ADNFCR-8000103-ID-800022334-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.